Showing results (51-60 of 202) with videos related to
Sort By:
Pageof 21
Cancer|April 7, 2006
Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancerDonald L Trump, Douglas M Potter, Josephia Muindi, et al.Clinical Breast Cancer|June 1, 2022
Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database AnalysisDebra Patt, Xianchen Liu, Benjamin Li, et al.The Journal of Clinical Endocrinology and Metabolism|October 19, 2006
Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trialSusan L Greenspan, Rajib K Bhattacharya, Susan M Sereika, et al.Archives of Pathology & Laboratory Medicine|November 9, 2006
Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 casesNicole Nicosia Esposito, Deepak Mohan, Adam Brufsky, et al.Journal of Andrology|April 4, 2006
Inhibin-B levels in healthy young adult men and prepubertal boys: is obesity the cause for the contemporary decline in sperm count because of fewer Sertoli cells?Stephen J Winters, Chenxi Wang, Eiman Abdelrahaman, et al.Breast (Edinburgh, Scotland)|April 20, 2023
Real-world comparative effectiveness of palbociclib plus letrozole versus letrozole in older patients with metastatic breast cancerHope S Rugo, Xianchen Liu, Benjamin Li, et al.Cancer Causes & Control : CCC|November 1, 2011
Factors associated with mortality after breast cancer metastasisSu Yon Jung, Margaret Rosenzweig, Susan M Sereika, et al.Breast Cancer Research and Treatment|July 9, 2011
The effect of delays in treatment for breast cancer metastasis on survivalSu Yon Jung, Susan M Sereika, Faina Linkov, et al.Hypertension (Dallas, Tex. : 1979)|December 21, 2011
Comorbidity as a mediator of survival disparity between younger and older women diagnosed with metastatic breast cancerSu Yon Jung, Margaret Rosenzweig, Faina Linkov, et al.The Journal of Biological Chemistry|August 23, 2013
An isoform of C/EBPβ, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migrationBae-Hang Park, Sungho Kook, SeanBong Lee, et al.Pageof 21